Can you provide the average price target for PRECIGEN INC stock?
9 analysts have analysed PGEN and the average price target is 8.67 USD. This implies a price increase of 136.24% is expected in the next year compared to the current price of 3.67.
PRECIGEN INC (PGEN) Forecast, Price Target & Analyst Ratings
NASDAQ:PGEN • US74017N1054
Current stock price
3.67 USD
-0.22 (-5.66%)
At close:
3.6652 USD
0 (-0.13%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PRECIGEN INC (PGEN).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 12, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.08
- Revenue Estimate
- 24.48M
Price Target Details & History
Consensus Price Target and Range
Mean target
$8.67
Upside
+ 136.24%
From current price of $3.67 to mean target of $8.67, Based on 9 analyst forecasts
Low
$8.08
Median
$8.67
High
$9.45
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
9 Wall Street analysts provided a forecast for the next 12 months for PGEN. The average price target is 8.67 USD. This implies a price increase of 136.24% is expected in the next year compared to the current price of 3.67.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
PGEN was analyzed by 9 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about PGEN.
In the previous month the buy percentage consensus was at a similar level.
PGEN was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-26 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2026-03-26 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-19 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-08-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-15 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2025-08-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-12 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-05-15 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-03-20 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-03-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-14 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-15 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-08-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-06-04 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-06-03 | Stifel | Maintains | Buy -> Buy |
| 2024-06-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-15 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-05-15 | Stifel | Maintains | Buy -> Buy |
| 2024-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-22 | JP Morgan | Downgrade | Neutral -> Underweight |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 12, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.08
- Revenue Estimate
- 24.48M
- Revenue Q2Q
- 1,725.50%
- EPS Q2Q
- -9.29%
- Number of Analysts
- 4
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
PGEN is expected to report earnings on 5/12/2026. The consensus EPS estimate for the next earnings is -0.08 USD and the consensus revenue estimate is 24.48M USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
Full Analyst Estimates 2026 - 2033
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 26.9M 88.11% | 6.225M -76.86% | 3.925M -36.95% | 17.379M 342.78% | 100.53M 478.46% | 209.71M 108.60% | 337.73M 61.05% | 460.35M 36.31% | 612.97M 33.15% | 757.64M 23.60% | 903.93M 19.31% | 1.032B 14.17% | |
| EBITDA YoY % growth | -63.83M 17.79% | -82.255M -28.87% | -90.179M -9.63% | -129.54M -43.65% | -75.48M 41.73% | -5.1M 93.24% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -74.6M 18.38% | -88.923M -19.20% | -94.705M -6.50% | -120.577M -27.32% | -51.895M 56.96% | 29.25M 156.36% | 151.37M 417.50% | 248.64M 64.26% | 376.73M 51.52% | 499.83M 32.68% | 623.94M 24.83% | 724.09M 16.05% | |
| Operating Margin | -277.32% | -1,428.48% | -2,412.87% | -693.81% | -51.62% | 13.95% | 44.82% | 54.01% | 61.46% | 65.97% | 69.03% | 70.16% | |
| EPS YoY % growth | -0.34 27.66% | -0.39 -14.71% | -0.35 10.26% | -0.89 -251.43% | -0.18 85.07% | 0.08 141.67% | 0.61 700.00% | 0.77 25.00% | 0.81 5.33% | 0.74 -7.59% | 0.62 -16.44% | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.08 -9.29% | -0.06 37.67% | -0.03 97.59% | 0.00 100.00% |
| Revenue Q2Q % growth | 24.48M 1,725.50% | 31.314M 3,558.18% | 38.046M 1,202.05% | 46.716M 922.23% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -8.874M 60.73% | 714K 102.56% | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
35.68%
EPS Next 5 Year
21.57%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
168.85%
Revenue Next 5 Year
103.93%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
25.15%
EBIT Next 5 Year
N/A
PRECIGEN INC / PGEN Forecast FAQ
Can you provide the upcoming earnings date for PRECIGEN INC?
PRECIGEN INC (PGEN) will report earnings on 2026-05-12.
What are the consensus estimates for PGEN stock next earnings?
The consensus EPS estimate for the next earnings of PRECIGEN INC (PGEN) is -0.08 USD and the consensus revenue estimate is 24.48M USD.
What is the number of analysts for PGEN stock?
The number of analysts covering PRECIGEN INC (PGEN) is 9.